Immutable evidence record · ticker
Alnylam Pharmaceuticals, Inc. (A1LN34)
Published as observed on 18 August 2026 at 01:40 BST.
Alnylam Pharmaceuticals, Inc. has a not yet measurable company news read. Its latest completed weekly trend is negative.
- As of
- 18 Aug 2026, 01:40
- Scope
- company and instrument
- Evidence
- 4 items
- Independent sources
- 0
- Country
- Brazil
- Sector
- Healthcare
- Previous read
- 50.000
- Change
- —
Verification
Evidence & related research
Company chart →Technicals & Market Dynamics →Technical Research Pack →Company news sentiment →Current financial news →
This is dated market research. Coverage may be delayed, incomplete or unavailable.
Cite this record:
Sharemaestro, Alnylam Pharmaceuticals, Inc. (A1LN34), 2026-08-18, https://sharemaestro.com/evidence/996332ed-5c6d-441a-9b88-403f6f823b83/
Record checksum b153da3e554d8151502009f9f08913f58f7acd64be9e23b57559c08c16cc2e6e
